Magellan BioScience Group, Inc. Awarded SBIR Grant for anti-Malarial Drug Discovery Collaboration with University of South Florida
Magellan BioScience Group, Inc. (Magellan), a pioneer in innovative drug discovery and development from marine microbial sources, and the University of South Florida (USF) announced today that they have been awarded a Phase I Small Business Innovative Research Grant (SBIR) from the National... - July 06, 2007
Thrombotargets Corp. and Magellan Bioscience Group, Inc. to Collaborate on Identification of Novel Hits from Both Marine Derivate and Natural Products
Thrombotargets Corporation and Magellan Bioscience Group, Inc. today announced the formation of drug discovery joint venture. Under the terms of this agreement, Magellan Bioscience Group, Inc. will provide to Thrombotargets its compounds and extracts from fermentation broths of marine-isolated... - June 16, 2007
Press Releases 1 - 2 of 2